{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:20:56Z","timestamp":1790796056183,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.niox.2024.01.008","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T20:45:16Z","timestamp":1706993116000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease"],"prefix":"10.1016","volume":"144","author":[{"given":"Parul","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9469-8080","authenticated-orcid":false,"given":"Ravindra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2024.01.008_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Ann. Rev. Path."},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11739-019-02160-x","article-title":"Sickle cell disease: a review for the internist","volume":"14","author":"Pinto","year":"2019","journal-title":"Intern. Emerg. Med."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/17474086.2020.1758555","article-title":"Sickle cell disease as a vascular disorder","volume":"13","author":"Ofori-Acquah","year":"2020","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.niox.2024.01.008_bib4","series-title":"Global, Regional, and National Prevalence and Mortality Burden of Sickle Cell Disease, 2000-2021: a Systematic Analysis from the Global Burden of Disease Study 2021","year":"2023"},{"key":"10.1016\/j.niox.2024.01.008_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exphem.2020.08.008","article-title":"Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials","volume":"92","author":"Ali","year":"2020","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.niox.2024.01.008_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"Sci. World J."},{"issue":"9757","key":"10.1016\/j.niox.2024.01.008_bib7","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"2\u20133","key":"10.1016\/j.niox.2024.01.008_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/2049463720920682","article-title":"Mechanisms of pain in sickle cell disease","volume":"15","author":"Takaoka","year":"2021","journal-title":"Br. J. Pain"},{"issue":"5","key":"10.1016\/j.niox.2024.01.008_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2005.08.002","article-title":"Sickle cell vaso-occlusion","volume":"19","author":"Chiang","year":"2005","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management","volume":"105","author":"Darbari","year":"2020","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.niox.2024.01.008_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2022.04.011","article-title":"Targeting endothelial dysfunction and inflammation","volume":"168","author":"Wang","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.niox.2024.01.008_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.663886","article-title":"Targeting neutrophil adhesive events to address vaso-occlusive crisis in sickle cell patients","volume":"12","author":"Morikis","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.niox.2024.01.008_bib14","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1038\/sj.thj.6200452","article-title":"Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium","volume":"5","author":"Elion","year":"2004","journal-title":"Hematol. J."},{"issue":"4 Suppl 6","key":"10.1016\/j.niox.2024.01.008_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.seminhematol.2004.08.003","article-title":"Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease","volume":"41","author":"Saunthararajah","year":"2004","journal-title":"Semin. Hematol."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.seminhematol.2018.04.008","article-title":"Fetal hemoglobin induction by epigenetic drugs","volume":"55","author":"Lavelle","year":"2018","journal-title":"Semin. Hematol."},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3324\/haematol.2021.278952","article-title":"Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea","volume":"107","author":"Allard","year":"2022","journal-title":"Haematologica"},{"issue":"2013","key":"10.1016\/j.niox.2024.01.008_bib18","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/asheducation-2013.1.362","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies, Hematology","author":"Manwani","year":"2013","journal-title":"Am Soc Hematol. Education Program"},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib19","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V96.7.2451","article-title":"Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion","volume":"96","author":"Belcher","year":"2000","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.niox.2024.01.008_bib20","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.clinbiochem.2009.06.024","article-title":"Hemoglobin disorders and endothelial cell interactions","volume":"42","author":"Conran","year":"2009","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/imr.13146","article-title":"Neutrophils as drivers of vascular injury in sickle cell disease","volume":"314","author":"Torres","year":"2023","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.niox.2024.01.008_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.biocel.2006.01.010","article-title":"Sickle cell disease and nitric oxide: a paradigm shift?","volume":"38","author":"Mack","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.hoc.2013.11.006","article-title":"Inflammatory mediators of endothelial injury in sickle cell disease","volume":"28","author":"Hoppe","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajh.23613","article-title":"A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia","volume":"89","author":"Belfer","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"15","key":"10.1016\/j.niox.2024.01.008_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153775","article-title":"Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS?","volume":"20","author":"Meza","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2613.1999.00137.x","article-title":"Endothelial nitric oxide in humans in health and disease","volume":"80","author":"Vallance","year":"1999","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.niox.2024.01.008_bib28","volume":"vol. 9","author":"Tenopoulou","year":"2020"},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1535370220976397","article-title":"Nitric oxide and sickle cell disease-Is there a painful connection?","volume":"246","author":"Hallmark","year":"2021","journal-title":"Exp. Biol. Med."},{"issue":"8","key":"10.1016\/j.niox.2024.01.008_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/hh0801.089861","article-title":"Nitric oxide insufficiency, platelet activation, and arterial thrombosis","volume":"88","author":"Loscalzo","year":"2001","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib31","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s10103-022-03551-x","article-title":"Nitric oxide storage levels modulate vasodilation and the hypotensive effect induced by photobiomodulation using an aluminum gallium arsenide (AlGaAs) diode laser (660 nm)","volume":"37","author":"Buzinari","year":"2022","journal-title":"Laser Med. Sci."},{"issue":"2\u20133","key":"10.1016\/j.niox.2024.01.008_bib32","first-page":"121","article-title":"Nitric oxide, vasodilation and the red blood cell","volume":"51","author":"Simmonds","year":"2014","journal-title":"Biorheology"},{"issue":"11","key":"10.1016\/j.niox.2024.01.008_bib33","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: an endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.freeradbiomed.2003.11.032","article-title":"The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation","volume":"36","author":"Gladwin","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2024.01.008_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassemia","author":"Morris","year":"2008","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCULATIONAHA.110.008698","article-title":"Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion","volume":"124","author":"Donadee","year":"2011","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib37","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.niox.2024.01.008_bib38","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood.V92.10.3924","article-title":"Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes","volume":"92","author":"Sultana","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.niox.2024.01.008_bib39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2015.07.018","article-title":"Oxidative stress in \u03b2-thalassaemia and sickle cell disease","volume":"6","author":"Voskou","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.niox.2024.01.008_bib40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","article-title":"The red blood cell-inflammation vicious circle in sickle cell disease","volume":"11","author":"Nader","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.blre.2015.08.005","article-title":"The role of blood rheology in sickle cell disease","volume":"30","author":"Connes","year":"2016","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/iub.584","article-title":"Role of oxidative stress in the pathogenesis of sickle cell disease","volume":"64","author":"Chirico","year":"2012","journal-title":"IUBMB Life"},{"issue":"10","key":"10.1016\/j.niox.2024.01.008_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10101608","article-title":"The role of RBC oxidative stress in sickle cell disease: from the molecular basis to pathologic implications","volume":"10","author":"Wang","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10020296","article-title":"Sickle cell disease: role of oxidative stress and antioxidant therapy","volume":"10","author":"Vona","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00062752-200303000-00001","article-title":"An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy","volume":"10","author":"Reiter","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.niox.2024.01.008_bib47","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.2741\/3084","article-title":"Role of oxidative stress and nitric oxide in atherothrombosis","author":"Lubos","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.niox.2024.01.008_bib48","article-title":"The worst things in life are free: the role of free heme in sickle cell disease","volume":"11","author":"Gbotosho","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trsl.2009.10.004","article-title":"Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease","volume":"155","author":"Kollander","year":"2010","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.21582","article-title":"Endothelial nitric oxide synthase and nitric oxide regulate endothelial tissue factor expression in vivo in the sickle transgenic mouse","volume":"85","author":"Solovey","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"11","key":"10.1016\/j.niox.2024.01.008_bib51","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ajh.26308","article-title":"Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease","volume":"96","author":"Hebbel","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.niox.2024.01.008_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147749","article-title":"GTP cyclohydroxylase1 (GCH1): role in neurodegenerative diseases","volume":"888","author":"Gupta","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.niox.2024.01.008_bib53","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1089\/ars.2013.5566","article-title":"Tetrahydrobiopterin in cardiovascular health and disease","author":"Bendall","year":"2014","journal-title":"Antioxidants Redox Signal."},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib54","first-page":"259","article-title":"Tetrahydrobiopterin synthesis and biological function","volume":"46","author":"Wang","year":"2015","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"issue":"5","key":"10.1016\/j.niox.2024.01.008_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051037","article-title":"Tetrahydrobiopterin: beyond its traditional role as a cofactor","volume":"12","author":"Eichwald","year":"2023","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","article-title":"Nitric oxide and endothelial dysfunction","volume":"36","author":"Cyr","year":"2020","journal-title":"Crit. Care Clin."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.ATV.18.1.27","article-title":"Cytokines stimulate GTP cyclohydrolase I gene expression in cultured human umbilical vein endothelial cells, Arterioscler","volume":"18","author":"Katusic","year":"1998","journal-title":"Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjms.2020.06.007","article-title":"The story of nitric oxide, sepsis and methylene blue: a comprehensive pathophysiologic review","volume":"360","author":"Saha","year":"2020","journal-title":"Am. J. Med. Sci."},{"issue":"18","key":"10.1016\/j.niox.2024.01.008_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189925","article-title":"Cyclic GMP-dependent regulation of vascular tone and blood pressure involves cysteine-rich LIM-only protein 4 (CRP4)","volume":"22","author":"L\u00e4ngst","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib61","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/0003319720987752","article-title":"Endothelial dysfunction and its clinical implications","volume":"72","author":"Poredos","year":"2021","journal-title":"Angiology"},{"issue":"17","key":"10.1016\/j.niox.2024.01.008_bib62","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1074\/jbc.M010612200","article-title":"The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide","volume":"276","author":"Cominacini","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.niox.2024.01.008_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.925923","article-title":"Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis","volume":"9","author":"Jiang","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib64","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cbin.10969","article-title":"De novo tetrahydrobiopterin biosynthesis is impaired in the inflammed striatum of parkin((-\/-)) mice","volume":"42","author":"de Paula Martins","year":"2018","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/18756212MTA1oOTYh3","article-title":"Endothelial dysfunction and inflammatory markers of vascular disease","volume":"19","author":"Balta","year":"2021","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010238","article-title":"Endothelial dysfunction and advanced glycation end products in patients with newly diagnosed versus established diabetes: from the CORDIOPREV study","volume":"12","author":"de la Cruz-Ares","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib67","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/15353702211068522","article-title":"Sickle cell disease as an accelerated aging syndrome","volume":"247","author":"Idris","year":"2022","journal-title":"Exp. Biol. Med."},{"issue":"9","key":"10.1016\/j.niox.2024.01.008_bib68","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1089\/ars.2020.8112","article-title":"Oxidative stress, GTPCH1, and endothelial nitric oxide synthase uncoupling in hypertension","volume":"34","author":"Wu","year":"2021","journal-title":"Antioxidants Redox Signal."},{"issue":"5","key":"10.1016\/j.niox.2024.01.008_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11050967","article-title":"Redox balance in \u03b2-thalassemia and sickle cell disease: a love and hate relationship","volume":"11","author":"Bou-Fakhredin","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.niox.2024.01.008_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/antiox8070218","article-title":"LOX-1: regulation, signaling and its role in atherosclerosis","volume":"8","author":"Kattoor","year":"2019","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.niox.2024.01.008_bib72","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","article-title":"Role of ox-LDL and LOX-1 in atherogenesis","volume":"26","author":"Kattoor","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/nyas.13984","article-title":"Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives","volume":"1443","author":"Tian","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/s13063-023-07538-z","article-title":"Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial","volume":"24","author":"Rees","year":"2023","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14360","article-title":"Red blood cells: the forgotten player in hemostasis and thrombosis","volume":"17","author":"Weisel","year":"2019","journal-title":"J. Thromb. Haemostasis"},{"issue":"2\u20133","key":"10.1016\/j.niox.2024.01.008_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/CH-189009","article-title":"Nitric oxide pathology and therapeutics in sickle cell disease","volume":"68","author":"Kim-Shapiro","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib78","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bph.12832","article-title":"Measurement of NO in biological samples","volume":"172","author":"Csonka","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib79","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.bpj.2016.06.023","article-title":"Glycoprotein Ib-IX-V complex transmits cytoskeletal forces that enhance platelet adhesion","volume":"111","author":"Feghhi","year":"2016","journal-title":"Biophys. J."},{"issue":"23","key":"10.1016\/j.niox.2024.01.008_bib80","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1161\/01.CIR.98.23.2629","article-title":"Glycoprotein IIb\/IIIa integrin blockade","volume":"98","author":"Madan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2024.01.008_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-0-387-09789-3_5","article-title":"Platelet glycoprotein VI","volume":"640","author":"Jung","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5414\/CPP43255","article-title":"P-selectin (CD62p) and P-selectin glycoprotein ligand-1 (PSGL-1) polymorphisms: minor phenotypic differences in the formation of platelet-leukocyte aggregates and response to clopidogrel","volume":"43","author":"Klinkhardt","year":"2005","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2011.04.018","article-title":"P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation","volume":"128","author":"Th\u00e9or\u00eat","year":"2011","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0092-8674(95)90174-4","article-title":"PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus","volume":"83","author":"Pouyani","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.niox.2024.01.008_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2016.11.007","article-title":"Targeting P-selectin glycoprotein ligand-1\/P-selectin interactions as a novel therapy for metabolic syndrome","volume":"183","author":"Patel","year":"2017","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib86","first-page":"1","article-title":"Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis","volume":"6","author":"Tomaiuolo","year":"2017","journal-title":"Interv. Cardiol. Clin."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib87","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCRESAHA.117.310939","article-title":"Translational implications of platelets as vascular first responders","volume":"122","author":"Becker","year":"2018","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.niox.2024.01.008_bib88","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/HYPERTENSIONAHA.112.198465","article-title":"Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure","volume":"60","author":"Yildirim","year":"2012","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.niox.2024.01.008_bib89","article-title":"Inhaled nitric oxide for treating pain crises in people with sickle cell disease","volume":"7","author":"Aboursheid","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib90","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ejh.13212","article-title":"Insight into the complex pathophysiology of sickle cell anaemia and possible treatment","volume":"102","author":"Piccin","year":"2019","journal-title":"Eur. J. Haematol."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0104-4230(11)70053-7","article-title":"Is inhaled nitric oxide therapy more effective or safer than the conventional treatment for the treatment of vaso-occlusive crises in sickle-cell anemia?","volume":"57","author":"Moreira","year":"1992","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0037-1963(01)90027-7","article-title":"Nitric oxide therapy in sickle cell disease","volume":"38","author":"Gladwin","year":"2001","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.niox.2024.01.008_bib93","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.niox.2022.01.007","article-title":"Nitric oxide: clinical applications in critically ill patients","volume":"121","author":"Redaelli","year":"2022","journal-title":"Nitric Oxide"},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bjh.17312","article-title":"Sickle cell disease: progress towards combination drug therapy","volume":"194","author":"Pace","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCRESAHA.119.315626","article-title":"Role of nitric oxide carried by hemoglobin in cardiovascular physiology: developments on a three-gas respiratory cycle","volume":"126","author":"Premont","year":"2020","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib96","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1164\/rccm.202108-1930OC","article-title":"Arginine therapy and cardiopulmonary hemodynamics in hospitalized children with sickle cell anemia: a prospective, double-blinded, randomized placebo-controlled clinical trial","volume":"206","author":"Onalo","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib97","first-page":"48","article-title":"The pharmacodynamics of L-arginine","volume":"20","author":"B\u00f6ger","year":"2014","journal-title":"Alternative Ther. Health Med."},{"issue":"3","key":"10.1016\/j.niox.2024.01.008_bib98","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2125.1999.00883.x","article-title":"Pharmacokinetics of intravenous and oral L-arginine in normal volunteers","volume":"47","author":"Tangphao","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.niox.2024.01.008_bib99","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3324\/haematol.2013.086637","article-title":"A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.niox.2024.01.008_bib100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-030-74180-8_10","article-title":"Role of L-arginine in nitric oxide synthesis and health in humans","volume":"1332","author":"Wu","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.niox.2024.01.008_bib101","first-page":"167","article-title":"The role of the arginine metabolome in pain: implications for sickle cell disease","volume":"9","author":"Bakshi","year":"2016","journal-title":"J. Pain Res."},{"issue":"5","key":"10.1016\/j.niox.2024.01.008_bib102","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4187\/respcare.03308","article-title":"Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use","volume":"60","author":"Todd Tzanetos","year":"2015","journal-title":"Respir. Care"},{"issue":"5","key":"10.1016\/j.niox.2024.01.008_bib103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01213011-200505000-00008","article-title":"Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: a relation with the -786T>C polymorphism","volume":"15","author":"Abe","year":"2005","journal-title":"Pharmacogenetics Genom."},{"issue":"9","key":"10.1016\/j.niox.2024.01.008_bib104","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jama.2011.235","article-title":"Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial","volume":"305","author":"Gladwin","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.niox.2024.01.008_bib105","article-title":"Inhaled nitric oxide for treating pain crises in people with sickle cell disease","volume":"7","author":"Aboursheid","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.niox.2024.01.008_bib106","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17474086.2019.1591948","article-title":"An update on arginine in sickle cell disease","volume":"12","author":"Benites","year":"2019","journal-title":"Expert Rev. Hematol."},{"issue":"2","key":"10.1016\/j.niox.2024.01.008_bib107","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.hoc.2013.11.008","article-title":"Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy","volume":"28","author":"Morris","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.niox.2024.01.008_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12123952","article-title":"Effect of a physical exercise program on the inflammatory response, cardiac functions, functional capacity, and quality of life in patients with sickle cell disease","volume":"12","author":"Antonelli Rossi","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.niox.2024.01.008_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48364-1","article-title":"Effect of acute exercise on RBC deformability and RBC nitric oxide synthase signalling pathway in young sickle cell anaemia patients","volume":"9","author":"Grau","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108986032400017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108986032400017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:10:26Z","timestamp":1761070226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108986032400017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":109,"alternative-id":["S108986032400017X"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2024.01.008","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide: A potential etiological agent for vaso-occlusive crises in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2024.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}